Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Healthy Returns: HHS Secretary RFK Jr. is making early moves that may affect vaccine access
Hims & Hers shares plunge 28% on concerns over weight loss business, margins
Athenahealth to offer Abridge's AI scribe to its network of thousands of doctors
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs
Chinese medical devices are in health systems across U.S., and the government and hospitals are worried
How the FDA's approval for food additives works, and why experts say a loophole allows companies to bypass it
